Lönnberg Harri
Department of Chemistry, University of Turku, FIN-20014 Turku, Finland.
Bioconjug Chem. 2009 Jun;20(6):1065-94. doi: 10.1021/bc800406a.
Olignucleotide-based drugs show promise as a novel form of chemotherapy. Among the hurdles that have to be overcome on the way of applicable nucleic acid therapeutics, inefficient cellular uptake and subsequent release from endosomes to cytoplasm appear to be the most severe ones. Covalent conjugation of oligonucleotides to molecules that expectedly facilitate the internalization, targets the conjugate to a specific cell-type or improves the parmacokinetics offers a possible way to combat against these shortcomings. Since workable chemistry is a prerequisite for biological studies, development of efficient and reproducible methods for preparation of various types of oligonucleotide conjugates has become a subject of considerable importance. The present review summarizes the advances made in the solid-supported synthesis of oligonucleotide conjugates aimed at facilitating the delivery and targeting of nucleic acid drugs.
基于寡核苷酸的药物有望成为一种新型化疗药物。在可应用的核酸治疗方法的发展过程中,必须克服的障碍中,细胞摄取效率低下以及随后从内体释放到细胞质似乎是最严重的问题。将寡核苷酸与有望促进内化的分子进行共价连接,使缀合物靶向特定细胞类型或改善药代动力学,为克服这些缺点提供了一种可能的方法。由于可行的化学方法是生物学研究的先决条件,因此开发高效且可重复的制备各种类型寡核苷酸缀合物的方法已成为一个相当重要的课题。本综述总结了在寡核苷酸缀合物的固相合成方面取得的进展,旨在促进核酸药物的递送和靶向。